In order to advance medical research in these important areas, it has been important to operate in an environment that accurately represents the BBB. As such, researchers have turned to animal subjects, something which comes with significant ethical and moral questions. The desire has been, therefore, to create some type of substitute for a living creature, but limits to current fabrication techniques had made such models impossible to produce. That is, until now. In an article recently published in the journal Small researchers detailed a breakthrough in high resolution 3D printing that has allowed them to “faithfully reproduc[e] the microcapillaries of the neurovascular system on a 1:1 scale.” As explained by Gianni Ciofani, Associate Professor at Polytechnic University of Torino and Principal Investigator of the Smart Bio-Interfaces group at the Italian Institute of Technology:
This mimicked BBB is important for developing methods by which pharmaceuticals can cross the boundary as there currently exist drug compounds that demonstrate great potential for addressing brain diseases, but that are currently unable to penetrate the barrier. The models created consist of porous microtubes that provide the scaffolding upon which endothelial cells can be grown in order to create a replica of the barrier present in the membrane. This will allow medical researchers to undertake their investigations in real time in an environment that accurately presents the circumstances under which the intervention would take place in the real world. As Ciofani described:
“The bio-hybrid BBB developed in our laboratories allows [one] to carry out high-throughput screening of different drugs/compounds/nanovectors, and to evaluate their ability to cross the BBB. Furthermore, our bio-hybrid platform allows [one] to rigorously study the BBB crossing by avoiding the use of animal models, thus overcoming the issues related to the scarce accessibility of the brain and limiting important ethical concerns.”
This is an important advance in the study of ways in which medicine can address diseases such as Alzheimer’s, Parkinson’s, and ALS as well as an important part of advancing treatments for those suffering from trauma induced brain damage. Ciofani concluded:
“The novelty of our work mainly consists in the fabrication of a reliable platform to carry out high throughput quantitative investigations of drug delivery to the brain. The in vitro model provides a closed system where the different variables such as drug concentration, blood flow speed, pH, and temperature can be easily turned and monitored, thus providing precious and detailed information about the BBB crossing in real time and at cellular/subcellular levels.”
“We strongly believe that nanotechnology-based solutions such as nanocarriers and nanovectors for thernostic applications show enormous potential for the treatment of brain pathologies…In this context, the new generation of remotely triggered smart nanomaterials represents, in our opinion, the future solution for the treatment of brain diseases. The BBB model we developed represents a powerful testing tool to achieve these goals.”
What do you think of this news? Let us know your thoughts; join the discussion of this and other 3D printing topics at 3DPrintBoard.com or share your thoughts below.[Source: Nanowerk]
You May Also Like
3D Printing Webinar and Event Roundup: May 16, 2021
Even as we get closer to the official start of summer, that doesn’t mean the amount of webinars, virtual events, and live events are going down; in fact, the opposite...
3D Printing Financials: SLM Solutions Reports Net Loss of €5.1M for 2021 First Quarter
SLM Solutions reported first-quarter results after the market closed on May 12, 2021, announcing losses and decreasing revenues. The German pioneer in metal 3D printing technology came out with a...
3D Printing Financials: 3D Systems Reports 7.7% Revenue Growth Driven by Increase in Healthcare Sales
For the first quarter ended March 31, 2021, 3D Systems delivered a combination of growth and profits. A leader in the 3D printing segment, the company reported 7.7% revenue growth,...
3D Printing Financials: Stratasys Regains Momentum with 3D Printing Sales Increase
As several national economies rebound from the COVID-19 pandemic, 3D printing companies are getting ready for greater demand for advanced manufacturing technologies. Thanks to an inherent demand-driven approach, additive manufacturing...
View our broad assortment of in house and third party products.